Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia
- Authors: Ciaccio, Marcello; Ziino, Ottavio; Giglio, Rosaria Vincenza; Ciaccio, Anna Maria; Iacona, Alessandro; Lucido, Giuseppe Dejan; Parisi, Elisa; Bivona, Giulia; Agnello, Luisa
- Publication year: 2020
- Type: Articolo in rivista
- OA Link: http://hdl.handle.net/10447/419303
Abstract
Objective: In this study, we investigated the roles of presepsin (PSP) and midregional proadrenomedullin (mr-proADM) in children with febrile neutropenia (FN) due to chemotherapy. Methods: We assessed 36 FN episodes in 26 children. Patients were classified into bacteremia (B) and fever of unknown origin (FUO) groups. We evaluated PSP and mr-proADM at admission (T0), after 24/48 h (T1), and after 5 days (T2). Results: PSP and mr-proADM levels were elevated at T0 and significantly decreased at T2. mr-proADM levels did not significantly differ between the B and FUO groups. PSP levels significantly differed between the B and FUO groups only at T1. Both PSP and mr-proADM levels at T0 were a predictor of length of hospital stay but not of the duration of fever. Finally, receiver operating characteristic curve analysis showed that PSP and mr-proADM had low diagnostic accuracy for blood culture positivity. Conclusion: PSP and mr-proADM display poor clinical usefulness for FN in oncologic children.